News

Business Wire

Verve Therapeutics Appoints Leading Biotechnology Executive Michael MacLean to its Board of Directors

PR Newswire

Owkin Bolsters Senior Team With Experienced Pharma Executives to Expand Platform and Strategic Partnerships

PR Newswire

Vestwell Partners with Wealthtech API Provider Bambu to Expand Investment Advice in Retirement Journey

Business Wire

Precision BioSciences Announces New Study Published in Nature Communications Using Engineered ARCUS Nuclease to Target Mutant Mitochondrial DNA In Vivo

PR Newswire

Innovaccer Partners With PatientPing to Empower Physicians With Real-Time Care Coordination

GlobeNewswire

AnHeart Therapeutics and Innovent Biologics Announce Exclusive License Agreement for Taletrectinib in Greater China

GlobeNewswire

Flywire Corporation Closes IPO and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Renaissance Capital Report

Gene editing biotech Verve Therapeutics files for a $100 million IPO

GlobeNewswire

Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945

PR Newswire

NFlection Therapeutics’ NFX-179 Gel Demonstrates Safety and Significant Reduction in p-ERK, a Key Biomarker Driving Neurofibroma Tumor Growth, in Positive Data From a 28-Day Phase 2a Clinical Trial

The Real Deal

Digital mortgage platform Snapdocs valued at more than $1B

GlobeNewswire

Singular Genomics Systems, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock

GlobeNewswire

Apellis and Sobi Report Positive Top-line Results from the Phase 3 PRINCE Study of EMPAVELI™ (pegcetacoplan) in Treatment-naïve Patients with PNH

Business Wire

Xilio Therapeutics Announces Clinical Trial Collaboration With Merck on Anti-CTLA-4 Monoclonal Antibody Program

GlobeNewswire

Flywire Announces Pricing of Initial Public Offering

PR Newswire

Innovent Announces First Patient Dosed in China in the Global Phase 3 Clinical Trial of Pemigatinib as the First-line Treatment of Unresectable or Metastatic Cholangiocarcinoma

Business Wire

Xilio Therapeutics to Present Preclinical Data Highlighting Anti-Tumor Activity and Tolerability of XTX202 at the 2021 ASCO Annual Meeting

GlobeNewswire

GeneTx and Ultragenyx Receive Clearance from Health Canada to Begin Clinical Study of GTX-102 in Canada for the Treatment of Angelman Syndrome

GlobeNewswire

Adagene Presents Clinical Data from NEObody™ Program, ADG106, Anti-CD137 Agonist, in an Abstract at ASCO 2021 Annual Meeting

FierceBiotech

ASCO: Adaptimmune’s cell therapy shrinks 39% of rare sarcomas

GlobeNewswire

Flywire Launches Roadshow for Proposed Initial Public Offering

PR Newswire

U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of People with Nonsquamous Non-Small Cell Lung Cancer

PR Newswire

LunaPBC Announces Joe Beery as New Chief Executive Officer

PR Newswire

Protenus Selected as One of the Best Places to Work in Healthcare for Fourth Straight Year

Business Wire

Caribou Biosciences Announces Appointment of Katy Rezvani, M.D., Ph.D. and Christopher Sturgeon, Ph.D. to its Scientific Advisory Board

PR Newswire

Innovent Will Publish Multiple Clinical Data at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire

Ultragenyx Announces Positive Multi-Year Durability Data from Ongoing Phase 1/2 Gene Therapy Studies and Data on HeLa 3.0 Manufacturing Platform at American Society of Gene & Cell Therapy 2021 Annual Meeting

GlobeNewswire

Apellis Announces U.S. Food and Drug Administration (FDA) Approval of EMPAVELI™ (pegcetacoplan) for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)

GlobeNewswire

Affinia Therapeutics Presents New Data and Updates on AAV Platform at American Society of Gene and Cell Therapy Annual Meeting

Business Wire

Xilio Therapeutics Presents Preclinical Tumor-Selective Activity and Tolerability Data for XTX101 at Frontiers in Cancer Immunotherapy Virtual Symposium

PR Newswire

Citrine Medicine Announces Strategic Partnership to bring Efmody® to China for Use in Adrenal Insufficiency (AI), including Congenital Adrenal Hyperplasia (CAH)

GlobeNewswire

First Preclinical Data from Adaptimmune’s Mesothelin HiT Program at ASGCT Demonstrate Antigen-specific Tumor Cell Killing in vitro and Complete Tumor Regression in an Animal Model

GlobeNewswire

Orchard Therapeutics Announces New England Journal of Medicine Publication of HSC Gene Therapy Data for ADA-SCID

GlobeNewswire

Beam Therapeutics Presents LNP Formulation Data at ASGCT and Reports First Quarter 2021 Financial Results

Reuters

Nio Lidar supplier Innovusion raises $64 million in funding

GlobeNewswire

Checkmate Pharmaceuticals Announces Clinical Supply Agreement with Regeneron to Evaluate Vidutolimod (CMP-001) in Combination with Libtayo® (cemiplimab)

Renaissance Capital Report

Singular Genomics Systems, a developer of next-gen sequencing tech, files for a $100 million IPO

Business Wire

Turnstone Biologics Announces Executive Leadership Promotions and Board Appointment

Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease

PR Newswire

Whatfix Announces Partnership with C-Clear Partners In Europe to Help Organizations Bolster Digital Transformation

GlobeNewswire

Flywire adds Gary Cunningham as Chief People Officer

Business Wire

Caribou Biosciences Announces Appointment of Industry Leader Andrew Guggenhime to its Board of Directors

Business Wire

Verve Therapeutics Appoints Industry Leader Sheila Mikhail to its Board of Directors

Business Wire

Xilio Therapeutics Appoints Christina Rossi to Its Board of Directors

PR Newswire

Protenus’ 5th Annual PANDAS Conference Cultivates Innovation and Compliance Best Practices Throughout COVID-19 Pandemic

GlobeNewswire

Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Potential Registration Trial of Vidutolimod (CMP-001) in Patients with Anti-PD-1 Refractory Advanced Melanoma

PR Newswire

Centivo launches new health plan for self-funded employers in Iowa utilizing Incirca Health Network, powered by MercyOne

GlobeNewswire

Affinia Therapeutics Closes $110 Million Series B Financing

GlobeNewswire

Flywire Files Registration Statement with SEC for Proposed Initial Public Offering

GlobeNewswire

Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease

PR Newswire

Carrot Fertility and Legacy Partner to Expand Access to Male Fertility Care

GeekWire

Freight forwarding software startup Logixboard lands $13M

PR Newswire

Announcing 1upHealth’s $25 million Series B led by F-Prime

PR Newswire

Innovent Announces First Patient Dosed in the Phase 2 Clinical Trial of IBI302, a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for Neovascular Age-Related Macular Degeneration

GlobeNewswire

Sana Biotechnology to Present Pre-Clinical Data at American Society of Gene & Cell Therapy Annual Meeting 2021

Business Today

Dental software start-up CareStack raises $22.5 million to fund expansion

GlobeNewswire

Ultragenyx Completes Successful End-of-Phase 2 Meeting with FDA and Finalizes Phase 3 Study Design for DTX301 Ornithine Transcarbamylase (OTC) Gene Therapy Program

GlobeNewswire

Bamboo Selects Snapsheet’s Claims Management Software Platform to Power and Streamline Claims Processes

PR Newswire

Papaya Announces Tools for Best-in-Class Employee Experience

Sifted

Proximie raises $38m for augmented reality surgery

GlobeNewswire

Beam Therapeutics Publishes Data Highlighting Ability to Rationally Design Base Editors for Precise Editing

PR Newswire

Citrine Medicine and Sinopharm Group Announce Strategic Partnership to Broaden and Accelerate Access to Rare Disease Drugs in China

Forbes

This Startup Raised $25 Million To Liberate Your Healthcare Data In The Cloud

PR Newswire

Former Blackboard VP of Engineering to Join Protenus

PR Newswire

Benchling Appoints Krista Anderson-Copperman to Its Board of Directors

GlobeNewswire

Adagene Presents Preclinical Data from Lead SAFEbody™ Program, ADG126, at the American Association for Cancer Research (AACR) Annual Meeting 2021

Business Wire

Xilio Therapeutics Strengthens Management Team with R&D Leadership Appointments

PR Newswire

onehome Partners with Devoted Health to Bring Post-Acute Home-Based Care to Medicare Advantage Members in Arizona, Ohio and San Antonio, TX

Business Wire

Precision BioSciences Appoints Stanley R. Frankel, M.D. to Board of Directors

PR Newswire

Innovent and Lilly Release Phase 3 Results of TYVYT® (Sintilimab Injection) as a Second-Line Treatment for Squamous Non-Small Cell Lung Cancer at AACR Annual Meeting 2021

PR Newswire

onehome Partners with Devoted Health to Bring Post-Acute Home-Based Care to Medicare Advantage Members in Arizona, Ohio and San Antonio, TX

GlobeNewswire

RightHand Robotics Introduces Next-Generation RightPick™ 3 Item-handling Robot System at ProMatDX

GlobeNewswire

Sana Biotechnology Presents Preclinical Data at American Association for Cancer Research Annual Meeting 2021

Business Wire

Firefly Health Closes $40M Series B Led by Andreessen Horowitz (a16z)

Business Wire

n-Lorem Foundation Partners with Ultragenyx to Bolster Development of Personalized Medicines for Patients with Ultra-Rare Diseases

PR Newswire

Benchling Hires Richard Wong as CFO and Zach Powers as CISO

BioSpace

Caribou Biosciences is Armoring Cells to Fight Disease Through CRISPR

PR Newswire

ONTOZRY® (cenobamate) receives European Commission approval for the treatment of drug-resistant focal-onset seizures in adults

PR Web

Iora Health and Devoted Health Partner in Phoenix

Business Wire

Xilio Therapeutics Strengthens Leadership Team with the Addition of Two Executives

GlobeNewswire

Leyden Labs to Unlock a New Generation of Preventative Medicines against Known and Future Viruses by Securing a €40 Million Series A from GV (formerly Google Ventures), F-Prime and Casdin Capital

Patient Ping

Clearlake Capital and Insight Partners-backed Appriss Health Acquires PatientPing to Deliver Comprehensive Care Coordination Solutions

Forbes

Virtual Reality Startup Raises $29 Million To Help With Chronic Pain

PR Newswire

Citrine Medicine Announces Receipt of Clinical Trial Waiver from the National Medical Products Administration (NMPA) in China for Narcolepsy Therapy Wakix® (pitolisant) and Partnership With Chinese Alliance for Rare Diseases (CARD)

PR Newswire

Tradier Announces The Acquisition of Popular Commission Free Mobile Trading App Rho

Business Wire

WellAir Announces Appointment of Brad Niemann as Executive Vice President of Healthcare

YourStory

OZiva raises $12M Series B investment by Eight Road Ventures, F-Prime Capital, and Matrix Partners Read more at: https://yourstory.com/2021/03/funding-alert-oziva-raises-12-million-series-b-investment

GlobeNewswire

Flywire Launches eStore to Enable Digital Commerce Experiences for Clients

GlobeNewswire

FUJIFILM Cellular Dynamics and Sana Biotechnology Announce License Agreement for the Development of iPSC-Derived Cell Therapies

GlobeNewswire

Adagene Announces First Patients Dosed in Global Phase 1 Clinical Trial of ADG126, Lead SAFEbody™ Program